[1]樊芳,马清敏,赵智华,等.K115对TGF-β1诱导的人Tenon 囊成纤维细胞增殖和迁移的影响及其机制[J].眼科新进展,2021,41(4):301-305.[doi:10.13389/j.cnki.rao.2021.0063]
　FAN Fang,MA Qingmin,ZHAO Zhihua,et al.Effects of Rho protein kinase inhibitor K115 on proliferation and migration of human Tenon’s fibroblasts induced by TGF-β1 and its mechanisms[J].Recent Advances in Ophthalmology,2021,41(4):301-305.[doi:10.13389/j.cnki.rao.2021.0063]
点击复制

K115对TGF-β1诱导的人Tenon 囊成纤维细胞增殖和迁移的影响及其机制/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年4期
页码:
301-305
栏目:
实验研究
出版日期:
2021-04-05

文章信息/Info

Title:
Effects of Rho protein kinase inhibitor K115 on proliferation and migration of human Tenon’s fibroblasts induced by TGF-β1 and its mechanisms
作者:
樊芳; 马清敏; 赵智华; 李科军; 赵晓彬; 田净净; 贾志旸
050051　河北省石家庄市，河北省人民医院眼科
Author(s):
FAN Fang; MA Qingmin; ZHAO Zhihua; LI Kejun; ZHAO Xiaobin; TIAN Jingjing; JIA Zhiyang
Department of Ophthalmology,Hebei General Hospital,Shijiazhuang 050051,Hebei Province,China
关键词:
K115; 转化生长因子-β1; 人Tenon 囊成纤维细胞; 青光眼; 细胞增殖; 细胞迁移
Keywords:
K115; transforming growth factor-β1; human Tenon’s fibroblasts; glaucoma;  cell proliferation;  cell migration
分类号:
R774
DOI:
10.13389/j.cnki.rao.2021.0063
文献标志码:
A
摘要:
目的　探讨K115对转化生长因子-β1(TGF-β1)诱导的人Tenon 囊成纤维细胞增殖和迁移的影响及其机制。方法　人Tenon 囊成纤维细胞取自于河北省人民医院眼科行青光眼手术的患者。采用CCK-8实验检测K115对人Tenon 囊成纤维细胞增殖的影响，筛选出TGF-β1对细胞增殖最佳作用浓度为5.0 μg·L-1，最佳作用时间为24 h；K115对细胞增殖起始作用浓度为5.0 μmol·L-1，最佳作用浓度为10.0 μmol·L-1。依据这两个浓度进行分组，分别是对照组（不加TGF-β1与K115），TGF-β1组（加5.0 μg·L-1 TGF-β1），TGF-β1+5.0 μmol·L-1 K115组（加5.0 μg·L-1TGF-β1和5.0 μmol·L-1的K115），TGF-β1+10.0 μmol·L-1 K115组（加5.0 μg·L-1 TGF-β1和10.0 μmol·L-1 的K115）。采用Transwell 实验检测K115对人Tenon 囊成纤维细胞迁移的影响；免疫荧光法测定人Tenon 囊成纤维细胞中α-SMA蛋白的表达；流式细胞仪检测细胞凋亡情况。对实验所得各指标进行统计学分析。结果　本研究细胞培养状态良好，6～8周可见人Tenon 囊成纤维细胞铺满培养瓶瓶底。用CCK-8 试剂盒检测各组细胞增殖情况结果显示,对照组、TGF-β1组、TGF-β1+5.0 μmol·L-1 K115组、TGF-β1+10.0 μmol·L-1 K115组光密度值分别为0.977±0.042、1.306±0.059、0.862±0.035、0.558±0.042，TGF-β1+5.0 μmol·L-1 K115组、TGF-β1+10.0 μmol·L-1 K115组光密度值均小于TGF-β1组 (均为P<0.05)，并且呈现浓度依赖性减小，K115浓度越大细胞增殖减少幅度越大。Transwell 实验结果显示，对照组、TGF-β1组、TGF-β1+5.0 μmol·L-1 K115组、TGF-β1+10.0 μmol·L-1 K115组迁移细胞数分别为（38.67±3.06）个、（81.00±4.00）个、（44.33±3.21）个、（23.67±2.52）个；TGF-β1+5.0 μmol·L-1 K115组与TGF-β1组比较，迁移细胞数降低，差异有统计学意义（P<0.05）；TGF-β1+10.0 μmol·L-1 K115组与对照组及TGF-β1组比较，迁移细胞数均明显降低，差异均有统计学意义（均为P<0.05）。各组细胞内α-SMA蛋白免疫荧光染色结果显示，对照组人Tenon 囊成纤维细胞胞浆内可见散在分布的绿色荧光物质，TGF-β1处理后24 h（TGF-β1组），胞浆内绿色丝状荧光物质明显增加，荧光强度差异有统计学意义（P<0.05）；与TGF-β1组比较，TGF-β1+5.0 μmol·L-1 K115组和 TGF-β1+10.0 μmol·L-1 K115组细胞胞浆内的荧光强度呈浓度依赖性减弱，K115浓度越高荧光强度减弱越明显(均为P<0.05)。流式细胞仪检测结果显示，对照组细胞凋亡率为（2.400±0.346）%,TGF-β1组为（0.900±0.173）%,TGF-β1+5.0 μmol·L-1 K115组为（1.333±0.252）%,TGF-β1+10.0 μmol·L-1 K115组为（1.067±0.058）%；TGF-β1组的细胞凋亡率较对照组降低（P<0.05）； TGF-β1+5.0 μmol·L-1 K115组和TGF-β1+10.0 μmol·L-1 K115组的细胞凋亡率均较对照组降低（均为P<0.05），而与TGF-β1组比较，差异均无统计学意义（均为P>0.05）。结论　K115对TGF-β1诱导的人Tenon 囊成纤维细胞增殖和迁移有明确的抑制作用，其作用机制可能与K115抑制了TGF-β1诱导的细胞内α-SMA的表达进而调控了细胞活化有关。
Abstract:
Objective　To study the regulation of Rho protein kinase inhibitor K115 on the proliferation and migration of human Tenon’s fibroblasts induced by TGF-β1 and its related mechanisms.Methods　Human Tenon’s fibroblasts were collected from patients undergoing glaucoma surgery in the Ophthalmology Department of Hebei Provincial People’s Hospital. CCK-8 assay was used to detect the effect of K115 on the proliferation of human Tenon’s fibroblasts. The optimal concentration of TGF-β1 on cell proliferation was 5.0 μg·L-1, and the optimal time was 24 hours. The initial concentration of K115 on cell proliferation was 5.0 μmol·L-1, and the optimal concentration was 10.0 μmol·L-1. According to the screening results of TGF-β1 and K115 concentration, the subsequent experiments were set as control group (without TGF-β1 and K115), TGF-β1 group (5.0 μg·L-1 TGF-β1 was added), TGF-β1+5.0 μmol·L-1 K115 group (5.0 μg·L-1TGF-β1 and 5.0 μmol·L-1 K115 were added), and TGF-β1+10.0 μmol·L-1 K115 group (5.0 μg·L-1TGF-β1 and 10.0 μmol·L-1 K115 were added). Transwell assay was used to detect the effect of K115 on the migration of human Tenon’s fibroblasts. The expression of α-SMA protein in human Tenon’s fibroblasts was determined by immunofluorescence assay. Cell apoptosis was detected by flow cytometry. Statistical analysis was carried out on data obtained from the experiment. Results　The cultured cells were in good condition, and human Tenon’s fibroblasts could be seen on the bottom of the culture bottle at 6-8 weeks. The results of CCK-8 kit showed that the optical density (OD) values of control group, TGF-β1 group, TGF-β1+5.0 μmol·L-1 K115 group, TGF-β1+10.0 μmol·L-1 K115 group were 0.977±0.042, 1.306±0.059, 0.862±0.035, 0.558±0.042, respectively. The OD values of TGF-β1+5.0 μmol·L-1 K115 group and TGF-β1+10.0 μmol·L-1 K115 group were lower than those of TGF-β1 group (both P<0.05), showing a concentration-dependent decrease. The decrease of cell proliferation was greater with the increase of K115 concentration. Transwell assay results showed that the migratory cell counts of control group, TGF-β1 group, TGF-β1+5.0 μmol·L-1 K115 group and TGF-β1+10.0 μmol·L-1 K115 group were 38.67±3.06, 81.00±4.00, 44.33±3.21 and 23.67±2.52, respectively. The migratory cell count in TGF-β1+5.0 μmol·L-1 K115 group was lower than that in TGF-β1 group, and the difference was statistically significant (P<0.05). Compared with the control group and TGF-β1 group, the migratory cell count in TGF-β1+10.0 μmol·L-1 K115 group was significantly decreased, and the differences were statistically significant (both P<0.05). There were scattered green fluorescent substances in the cytoplasm of human Tenon’s fibroblasts in the control group. After treatment with TGF-β1 for 24 h (TGF-β1 group), the amount of green filamentous fluorescent substances in the cytoplasm was significantly increased, and the difference of fluorescence intensity was statistically significant (P<0.05). Compared with TGF-β1 group, the intensity of green filamentous fluorescence in the cytoplasm of TGF-β1+5.0 μmol·L-1 K115 group and TGF-β1+10.0 μmol·L-1 K115 group decreased in a concentration-dependent manner. The higher the concentration of K115 was, the more obviously the fluorescence intensity decreased (both P<0.05). The results of flow cytometry showed that the apoptosis rate in control group was (2.400±0.346) %, TGF-β1 group was (0.900±0.173) %, TGF-β1+5.0 μmol·L-1 K115 group was (1.333±0.252) %, and TGF-β1+10.0 μmol·L-1 K115 group was (1.067±0.058)%.Conclusion　K115 has a definite inhibitory effect on TGF-β1 induced human Tenon’s fibroblasts proliferation and migration. The mechanism might be that K115 inhibitions the expression of α-SMA induced by TGF-β1 and then regulates the activation of cells.

参考文献/References:

［1］　QUIGLEY H A,BROMAN A T.The number of people with glaucoma worldwide in 2010 and 2020［J］.Br J Ophthalmol,2006,90(3):262-267.
［2］　THAM Y C,LI X,WONG T Y,QUIGLEY H A,AUNG T,CHENG C Y.Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis［J］.Ophthalmology,2014,121(11):2081-2090.
［3］　SCHLUNCK G,MEYER-TER-VEHN T,KLINK T,GREHN F.Conjunctival fibrosis following filtering glaucoma surgery［J］.Exp Eye Res,2016,142:76-82.
［4］　HONJO M,TANIHARA H.Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma［J］.Jpn J Ophthalmol,2018,62(2):109-126.
［5］　SCHEHLEIN E M,ROBIN A L.Rho-associated kinase inhibitors: evolving strategies in glaucoma treatment［J］.Drugs,2019,79(10):1031-1036.
［6］　BERRINO E,SUPURAN C T.Rho-kinase inhibitors in the management of glaucoma［J］.Expert Opin Ther Pat,2019,29(10):817-827.
［7］　TANNA A P,JOHNSON M.Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension［J］.Ophthalmology,2018,125(11):1741-1756.
［8］　TANIHARA H,INOUE T,YAMAMOTO T,KUWAYAMA Y,ABE H,FUKUSHIMA A,et al.One-year clinical evaluation of 0.4% ripasudil (K115) in patients with open-angle glaucoma and ocular hypertension［J］.Acta Ophthalmol,2016,94(1):E26-E34.
［9］　TANIHARA H,INOUE T,YAMAMOTO T,KUWAYAMA Y,ABE H,SUGANAMI H,et al.Additive intraocular pressure-lowering effects of the rho kinase inhibitor ripasudil (k115) combined with timolol or latanoprost: a report of 2 randomized clinical trials［J］.JAMA Ophthalmol,2015,133(7):755-761.
［10］　AMANO M,NAKAYAMA M,KAIBUCHI K.Rho-Kinase/ROCK: a key regulator of the cytoskeleton and cell polarity［J］.Cytoskeleton,2010,67(9):545-554.
［11］　VAN DE VELDE S,DE GROEF L,STALMANS I,MOONS L,VAN HOVE I.Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics［J］.Prog Neurobiol,2015,131:105-119.
［12］　MOURA-COELHO N,TAVARES FERREIRA J,BRUXELAS C P,DUTRA-MEDEIROS M,CUNHA J P,PINTO PROENCA R.Rho kinase inhibitors-a review on the physiology and clinical use in ophthalmology［J］.Graefes Arch Clin Exp Ophthalmol,2019,257(6):1101-1117.
［13］　OKUMURA N,KINOSHITA S,KOIZUMI N.The role of rho kinase inhibitors in corneal endothelial dysfunction［J］.Curr Pharm Des,2017,23(4):660-666.
［14］　DEMIRYREK S,BAYSALMAN E,MAMMADOV A,DEMIRYREK A T.Contribution of the Rho-kinase to systemic sclerosis and behet’s disease［J］.Curr Pharm Des,2018,24(29):3402-3409.
［15］　UCHIDA T,HONJO M,YAMAGISHI R,AIHARA M.The anti-inflammatory effect of ripasudil (K115),a rho kinase (ROCK) inhibitor on endotoxin-induced uveitis in rats［J］.Invest Ophthalmol Vis Sci,2017,58(12):5584-5593.
［16］　FUTAKUCHI A,INOUE T,FUJIMOTO T,INOUE-MOCHITA M,KAWAI M,TANIHARA H.The effects of ripasudil (K115),a Rho kinase inhibitor,on activation of human conjunctival fibroblasts［J］.Exp Eye Res,2016,149:107-115.
［17］　SHU D Y,LOVICU F J.Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis［J］.Prog Retin Eye Res,2017,60:44-65.
［18］　YAMANAKA O,KITANO-IZUTANI A,TOMOYOSE K,REINACH P S.Pathobiology of wound healing after glaucoma filtration surgery［J］.BMC Ophthalmol,2015,15(Suppl 1):157.

相似文献/References:

[1]衡欣 陈悦.增生型糖尿病视网膜病变患者血清中转化生长因子-β1和结缔组织生长因子水平的变化及意义[J].眼科新进展,2013,33(4):000.
[2]陈艳蕾 郭海科 张洪洋 孟倩丽.兔Epi-LASIK上皮瓣弃留对角膜基质TGF-β1、bFGF表达及细胞凋亡的影响[J].眼科新进展,2013,33(12):000.
[3]陆燕,黄媛媛,蔡季平,等. SB431542和TGF-β1对甲状腺相关性眼病患者眼眶成纤维细胞α-SMA及CTGF基因表达的影响[J].眼科新进展,2015,35(3):210.[doi:10.13389/j.cnki.rao.2015.0057]
　LU Yan,HUANG Yuan-Yuan,CAl Ji-Ping,et al. Effects of SB431542 and TGF-B1 0n a-SMA and CTGF gene expression in orbital fibroblast of patients with thyroid-associated ophthalmolopathy[J].Recent Advances in Ophthalmology,2015,35(4):210.[doi:10.13389/j.cnki.rao.2015.0057]
[4]梁秀玮,何梦梅,蔡雯婷,等.缓激肽对转化生长因子-β1（TGF-β1）诱导视网膜色素上皮细胞发生上皮间充质转化的影响[J].眼科新进展,2018,38(11):1005.[doi:10.13389/j.cnki.rao.2018.0237]
　LIANG Xiu-Wei,HE Meng-Mei,CAI Wen-Ting,et al.Effects of bradykinin on TGF-β1-induced epithelial-mesenchymal transformation in ARPE-19 cells[J].Recent Advances in Ophthalmology,2018,38(4):1005.[doi:10.13389/j.cnki.rao.2018.0237]
[5]胡红利,肖中举.丹参酮ⅡA对人角膜基质细胞纤维化的抑制作用[J].眼科新进展,2018,38(12):1114.[doi:10.13389/j.cnki.rao.2018.0263]
　HU Hong-Li,XIAO Zhong-Ju.Inhibitory effect of tanshinone ⅡA on fibrosis of human corneal stromal cells[J].Recent Advances in Ophthalmology,2018,38(4):1114.[doi:10.13389/j.cnki.rao.2018.0263]
[6]展欣,朱子诚,孙思勤,等.激活蛋白1（AP-1）在豚鼠进展性近视巩膜重塑中与I型胶原的表达关系研究[J].眼科新进展,2019,39(2):129.[doi:10.13389/j.cnki.rao.2019.0029]
　ZHAN Xin,ZHU Zi-Cheng,SUN Si-Qin,et al.Expression changes of activator protein 1 and its correlation with collagen Ⅰ in the sclera remodeling of progressive myopia in guinea pigs[J].Recent Advances in Ophthalmology,2019,39(4):129.[doi:10.13389/j.cnki.rao.2019.0029]
[7]易琼,邹文进.不同浓度多西环素对碱烧伤大鼠角膜中转化生长因子β1和基质金属蛋白酶9表达的影响[J].眼科新进展,2019,39(5):401.[doi:10.13389/j.cnki.rao.2019.0092]
　YI Qiong,ZOU Wen-Jin.Effects of different concentrations of doxycycline on the expression of transforming growth factor-β1 and matrix metalloproteinase-9 in alkali-burnt corneas of rats[J].Recent Advances in Ophthalmology,2019,39(4):401.[doi:10.13389/j.cnki.rao.2019.0092]
[8]朱子诚,展欣,张楚,等.转录活性蛋白1在实验性近视眼豚鼠巩膜重塑中对I型胶原表达的调控作用[J].眼科新进展,2019,39(5):415.[doi:10.13389/j.cnki.rao.2019.0095]
　ZHU Zi-Cheng,ZHAN Xin,ZHANG Chu,et al.Effect of specificity protein 1 （Sp1）transcription factor on the expression of type I collagen in sclera remodeling of experimentally myopic guinea pigs[J].Recent Advances in Ophthalmology,2019,39(4):415.[doi:10.13389/j.cnki.rao.2019.0095]
[9]隋文君,高洪莲,刘奇奇,等.PPAR-γ受体激动剂罗格列酮对兔准分子激光角膜切削术后角膜上皮下雾状混浊的影响[J].眼科新进展,2019,39(8):732.[doi:10.13389/j.cnki.rao.2019.0167]
　SUI Wen-Jun,GAO Hong-Lian,LIU Qi-Qi,et al.Effects of peroxisome proliferator-activated receptor gamma agonist rosiglitazone on corneal haze after photorefractive keratectomy in rabbits[J].Recent Advances in Ophthalmology,2019,39(4):732.[doi:10.13389/j.cnki.rao.2019.0167]
[10]刘畅,蔡雯婷,苏途,等.槲皮素对转化生长因子β1介导的视网膜色素上皮细胞上皮-间质转化过程的影响[J].眼科新进展,2021,41(7):638.[doi:10.13389/j.cnki.rao.2021.0131]
　LIU Chang,CAI Wenting,SU Tu,et al.Effect of quercetin on transforming growth factor β1-induced epithelial-mesenchymal transition process in retinal pigment epithelial cells[J].Recent Advances in Ophthalmology,2021,41(4):638.[doi:10.13389/j.cnki.rao.2021.0131]

备注/Memo

备注/Memo:
国家自然科学基金资助 （编号：81700835)
更新日期/Last Update: 2021-04-05